Leveraging Med Device Expertise to Develop Combination Products
|
|
|
- Georgiana Freeman
- 6 years ago
- Views:
Transcription
1 Leveraging Med Device Expertise to Develop Combination Products 20 th Annual Drug Delivery Partnership Conference January 20, 2016 Dirk Smith VP of Technology Solutions Minnetronix, Inc.
2 250 employees, 20 years in business 100+ engineers with over 1.5M development hours on complex electromechanical medical devices, including drug delivery devices FDA-registered, ISO Certified Our medical device background: Development partner Med device manufacturer Technology developer
3 Minnetronix Experience with Combination Products Ultrasound nebulizer Design for manufacturability, test development and scale-up Photodynamic drug therapy light source Ground up design, concurrent with drug research Iontophoresis stimulator Next generation design and manufacturing Anesthesia delivery via battery-power device Multiple drug infusion pumps and systems Development of large volume and ambulatory pumps Insulin, chemotherapy and TPN applications
4 The Combination Product Development Paradigm From Early Development Considerations for Innovative Combination Products Guidance (FDA Office of Combination Products): When combining products such as drugs or biologics and devices that are customarily delivered using different regulatory paradigms, certain critical development issues, such as the interaction of the drug/biologic and device constituents, may not be readily apparent.
5 The Combination Product Development Paradigm Drug/Biologic Constituent Development cycles Pre-clinical/clinical testing Drug safety & compliance Device Constituent Design controls Usability / human factors Device safety & compliance Combination Product Drug/device interactions Clinical / Validation approach - IND or IDE Approval path (CBER, CDER, CDRH) System risk management - safety & efficacy Balanced/comprehensive QMS
6 Combination Product Resources Office of Combination Products: FDA Guidance Documents 01/2015 Current GMP Requirements for Combination Products 06/2011 Classification of Products as Drugs and Devices and Additional Product Classification Issues 04/2011 How to Write a Request for Designation 09/2006 Early Development Considerations for Innovative Combination Products Additional Work on the Challenges of Combination Products Articles, websites, courses, books, etc
7 The Device Constituent Perspective A Shared Mission Bringing new therapies to patients & clinicians with a Different Frame of Reference Development Cross-functional teams and technologies Time and Cost months and 7 figures($) Manufacturing High complexity, low-to-moderate volumes Anticipated product evolution Regulatory Process 510(k)/PMA Limited clinical trials w/small sample sizes
8 Complex Medical Device Regulatory Landscape Quality Systems QSR - 21 CFR Part 820 ISO Device Master Records & Design History Files Design controls - planning, requirements, design, verification & validation, risk management (ISO 14971), change management Compliance EN60601, Safety of Medical Electrical Equipment Software - IEC Usability and Human Factors - IEC EMC & Wireless, compliance and licenses Sterilization and biocompatibility
9 Challenges Unique to Device Development Complex, multi-technology systems and teams Multiple, concurrent engineering efforts Manufacturing, supply chain, quality & regulatory Third-party testing/certification/compliance DFM and scale-up Designing and building the first one is the easy part.. System testing, development through production How to test a combination product Critical requirements and essential performance Process validation Technology evolution Availability and obsolescence Leveraging new technology and balancing risk
10 Critical Combination Product Success Factors: The Device Partner Should Bring. Design through Manufacturing Expertise Proven design controls Experienced/professional/technical project managers DFx ( Design for Success mentality & processes) Prototyping & NPI Flexible, efficient manufacturing capabilities (Lean, SS, integration w/design)
11 Critical Combination Product Success Factors: The Device Partner Should Bring. A Positive Regulatory & Compliance Track Record Comprehensive quality system Successful FDA and ISO audit history Proactive standards and guidance document knowledge Regulatory submission experience & expertise
12 Critical Combination Product Success Factors: The Device Partner Should Bring. A relevant portfolio of products & technologies Applicable technologies for complex electromechanical devices Microfluidics Miniaturized pump and fluid control systems Safety critical software for life sustaining systems Wireless, implantable power and communications Track record of getting to the clinic
13 An Effective Device Partner will. Mitigate your device risks - technology/quality/reliability/ usability/safety/compliance/etc Bring knowledge and expertise - gained from an established track record of relevant technology & products Partner with you to manage the complex, cross-functional & concurrent demands of combination product development Prioritize critical business objectives and constraints bring a market appreciation with a systems perspective
14 Minnetronix A Unique Resource for Combination Product Commercialization Medical Device Systems Innovators Systems engineering and integration Software, hardware, electronic, and electromechanical design Valuable Technology for Better Outcomes Accelerating time to market and reducing development risk Creating market-focused solutions to maximize product value Providing Strategic Options Offering new types of engagements and partnerships Creating tailored strategies such as co-development ventures, spin-outs, or Newcos Developing new therapy solutions to unmet clinical needs
15 Questions and Discussion Saint Paul, MN USA
Combination Products Verification, Validation & Human Factors Sept. 12, 2017
Combination Products Verification, Validation & Human Factors Sept. 12, 2017 Speaker Scott Thiel Director, Navigant Consulting Regulatory consulting in Life Sciences industry with focus on medical devices,
Medical Electronics I S O. Member of Amalthea Group. Switzerland
Certified Management Systems Medical Member of Amalthea Group by Switzerland 13 4 8 5 From the analgesic pump to endoscopy products to heat therapy devices our services contribute to your market success.
Model Based Design Of Medical Devices
Model Based Design Of Medical Devices A Tata Elxsi Perspective Tata Elxsi s Solutions - Medical Electronics Abstract Modeling and Simulation (M&S) is an important tool that may be employed in the end-to-end
Medical Device Usability Engineering. Product and Service Design Innovation Consultancy
Medical Device Usability Engineering Product and Service Design Innovation Consultancy Delivering Meaningful Innovation PDD services Our integration of multiple disciplines means we offer a comprehensive
Implementing Quality Systems
Implementing Quality Systems CGMP By The Sea August 29, 2006 Chris Joneckis, Ph.D. Senior Advisor For CMC Issues Center For Biologics Evaluation And Research Add FDA Bar and Presentation Overview Driving
Building Quality into Medical Device Documentation and Impact of New Device Regulation (Context: Inhaled Drug Devices) v4
Building Quality into Medical Device Documentation and Impact of New Device Regulation (Context: Inhaled Drug Devices) v4 Paul Brooks SVP Healthcare Solutions Representing BSI Notified Body EU Medical
INTEGRATING HUMAN FACTORS AND USABILITY TESTING INTO MEDICAL DEVICE RISK MANAGEMENT
2014 CMBEC37 Conference Vancouver, BC May 21 23, 2014 INTEGRATING HUMAN FACTORS AND USABILITY TESTING INTO MEDICAL DEVICE RISK MANAGEMENT Florin Gheorghe, H.F. Machiel Van der Loos Department of Mechanical
Prof. Steven S. Saliterman. Department of Biomedical Engineering, University of Minnesota
Department of Biomedical Engineering, University of Minnesota http://saliterman.umn.edu/ 1) Device Discovery and Ideation 2) Medical Device Regulations 3) Product Life Cycle 4) Design Controls 5) Medical
4/8/2018. Prof. Steven S. Saliterman Department of Biomedical Engineering, University of Minnesota
Department of Biomedical Engineering, University of Minnesota http://saliterman.umn.edu/ 1) Device Discovery and Ideation 2) Medical Device Regulations 3) Product Life Cycle 4) Design Controls 5) Medical
FDA Centers of Excellence in Regulatory and Information Sciences
FDA Centers of Excellence in Regulatory and Information Sciences February 26, 2010 Dale Nordenberg, MD novasano HEALTH AND SCIEN Discussion Topics Drivers for evolution in regulatory science Trends in
Leader in Pharmaceutical Films
TSX-V: IGX OTCQX: IGXT Leader in Pharmaceutical Films Your Specialist in Contract Development & Manufacturing WE MAKE APPROVED DRUGS BETTER Our Mission We make approved drugs better, with next generation
Pre-clinical Development Support Services
Pre-clinical Development Support Services Enabling device development with unique understanding Our Company - Vascular Flow Technologies Vascular Flow Technologies (VFT) has evolved from a tiny surgeon
Connecting People, Science and Regulation
Connecting People, Science and Regulation Bethesda Towers 4350 East West Highway Suite 600 Bethesda, MD 20814 USA Tel: +1 (301) 656-5900 Fax: +1 (301) 986-0296 www.pda.org PDA Europe ggmbh Am Borsigturm
Bringing Technology and Product Development Best Practices Together for Successful Innovation
Bringing Technology and Product Development Best Practices Together for Successful Innovation April 18 19, 2018 * Boston Convention & Exhibition Center Preliminary Agenda AGENDA AT A GLANCE Day One Wednesday,
Prof. Steven S. Saliterman. Department of Biomedical Engineering, University of Minnesota
Department of Biomedical Engineering, University of Minnesota http://saliterman.umn.edu/ ISO 14971 Risk Management as Part of Design Control Human Factors and Usability Engineering Definitions How People
CENTER FOR DEVICES AND RADIOLOGICAL HEALTH. Notice to Industry Letters
CENTER FOR DEVICES AND RADIOLOGICAL HEALTH Standard Operating Procedure for Notice to Industry Letters PURPOSE This document describes the Center for Devices and Radiological Health s (CDRH s, or Center
Software as a Medical Device (SaMD)
Software as a Medical Device () Working Group Status Application of Clinical Evaluation Working Group Chair: Bakul Patel Center for Devices and Radiological Health US Food and Drug Administration NWIE
New Approaches to Safety and Risk Management
New Approaches to Safety and Risk Management 15 18 May 2011 The 3rd DIA China Annual Meeting, Bejjin, China Ayman Ayoub MD MSC (med) Safety Surveillance & Risk Management Pfizer Disclaimer The views/opinions
J. Lawrence Stevens, RAC 833 E. Rosedale Dr. East Alton, IL (office) (mobile)
J. Lawrence Stevens, RAC 833 E. Rosedale Dr. East Alton, IL 62024 314-499-5148 (office) 714-473-0863 (mobile) Larry@fdadeviceexpert.com INTRODUCTION: Over 20 years of FDA experience encompassing virtually
Coatings technology overview
Coatings technology overview Coatings technology and the chemistry of collaboration In a competitive global coatings market, the difference between merely surviving and thriving can often lie in the efficacy
Feature. Accelerate Business Development Contributing to Further Enhance Ophthalmic Treatment in Asia. 2020, our goal is to become #1 in
Feature Accelerate Business Development Contributing to Further Enhance Ophthalmic Treatment in Asia Based on our long-term strategic vision toward 2020, our goal is to become #1 in Asia in terms of our
Vice President, Regulatory Affairs, Clinical Research, and Quality Assurance AREAS OF EXPERTISE
Vice President, Regulatory Affairs, Clinical Research, and Quality Assurance AREAS OF EXPERTISE Medical Device Expert (21 years with FDA, 18 years in the device industry) Planning, implementing, and managing
CDRH INNOVATION INITIATIVE. February 2011 Center for Devices and Radiological Health U.S. Food and Drug Administration
CDRH INNOVATION INITIATIVE February 2011 Center for Devices and Radiological Health U.S. Food and Drug Administration 1 Table of Contents EXECUTIVE SUMMARY... 3 BACKGROUND... 4 Innovation and Medical Device
the SPD company Dr Clive Simon, Principal, The SPD Company.
the SPD company With decades of local and international experience at the coalface, The SPD Company s specialists have built a solid repertoire of in-depth technical knowledge within the highly-regulated
Quality by Design. Innovate Design Development Create value. Correct definition of QbD and its relation to product and process development
Innovate Development Create value Quality by Correct definition of QbD and its relation to product and process development Dr John Loveluck 42 Technology Ltd +44 1480 302700 john.loveluck@42technology.com
Intellectual Property, Vaccine Production and Technology Transfer
Intellectual Property, Vaccine Production and Technology Transfer Vaccine Industry Perspective P. Fournier, On behalf of IFPMA Bio Group 19-20 April 2004, WHO HQ, Geneva 1 OUTLINE General considerations
National Medical Device Evaluation System: CDRH s Vision, Challenges, and Needs
National Medical Device Evaluation System: CDRH s Vision, Challenges, and Needs Jeff Shuren Director, CDRH Food and Drug Administration Center for Devices and Radiological Health 1 We face a critical public
peace of mind For from development to commercial supply
For peace of mind from development to commercial supply aesica-pharma.com weshouldtalk@aesica-pharma.com @aesica CorporateBroEng_v2 0814 @ Aesica 2014 Your full service CDMO Our vision: To be the number
National Coordinated Registry Network (CRN) Think-tank
National Coordinated Registry Network (CRN) Think-tank The Value of Real World Data for Innovation within FDA What can CRNs offer? Murray Sheldon, MD Associate Director for Technology and Innovation FDA/CDRH
A Focus on Health Data Infrastructure, Capacity and Application of Outcomes Data
External Review of Pan-Canadian Health Organizations Thank you for the opportunity to provide input for your ongoing review of the Pan- Canadian Health Organizations (PCHOs). This submission is made on
Patent (novel, non-obvious and useful) vs. Innovate Yes - we CAN do both! The 2015 ASQ Innovation Conference September 19-20
Patent (novel, non-obvious and useful) vs. Innovate Yes - we CAN do both! The 2015 ASQ Innovation Conference September 19-20 Invention (Patent) vs. Innovation Education vs. Training Can we start with this
EU GMP Evolution or Revolution Scope and drivers for EU GMP changes. August Gordon Farquharson
EU GMP Evolution or Revolution Scope and drivers for EU GMP changes August 2015 Gordon Farquharson EU & PIC/S Harmonisation at IWG level now Slide 2 PharmOut 2015 EU & PIC/S Harmonisation (1) What does
FDA REGULATION OF DIGITAL HEALTH
FDA REGULATION OF DIGITAL HEALTH DIGITAL HEALTH LEGAL AND REGULATORY BOOTCAMP WHAT YOU DON T KNOW YOU DON T KNOW Table of Contents DIGITAL DIGITAL HEALTH LEGAL AND HEALTH REGULATORY LEGAL BOOTCAMP AND
ADVANCED PLASTICS. CBRN DEFENSE SYSTEMS
ADVANCED PLASTICS. CBRN DEFENSE SYSTEMS From mission critical breathing apparatus and medical device assemblies to life science and aerospace products, DWE has over 20 years of experience molding shared
Claudio Pincus, President, The Quantic Group R. Owen Richards, President, Quantic Regulatory Services Daniel Pincus, Consultant, The Quantic Group
FDA Compliance and Regulatory Symposium Understanding the FDA s Latest cgmp Guidances: Opportunities and Pitfalls Claudio Pincus, President, The Group R. Owen Richards, President, Regulatory Services Daniel
Pharmaceutical Manufacturing and Engineering Catalog Excerpt
Pharmaceutical Manufacturing and Engineering Catalog Excerpt PME 530 Introduction to Pharmaceutical Manufacturing Pharmaceutical manufacturing is vital to the success of the technical operations of a pharmaceutical
Learning from real world use
Learning from real world use Complementing medical device experience databases through analysis of social media. Medical & Healthcare Product and Service Design Innovation Consultancy Learning from real
Importance of ICH Guidance in Fulfilling Process Validation Requirements
Importance of ICH Guidance in Fulfilling Process Validation Requirements Presented by: Gamal Amer All rights reserved. Do not copy without permission. Principal 1 Premier Compliance Services, Inc. Process
Before I talk through the strategy itself, I want to tell you more about why
This presentation was given by Dr Annette Bramley, the Healthcare Technologies Theme leader. She thanked Professor Nelson and Professor Taylor for their presentations, and thanked everyone at the meeting
Navigating the Healthcare Innovation Cycle
Navigating the Healthcare Innovation Cycle Introduction: CIMIT s 20 + years of experience in facilitating more than 600 projects is that innovation in Healthcare is a learnable, teachable process, which
Office of Pharmaceutical Quality: Why, What, and How?
Office of Pharmaceutical Quality: Why, What, and How? Lawrence Yu, Ph.D. Deputy Director, Office of Pharmaceutical Quality FDA Center for Drug Evaluation and Research NIPTE Annual Scientific Conference
Value Paper. Are you PAT and QbD Ready? Get up to speed
Value Paper Are you PAT and QbD Ready? Get up to speed PAT and Quality-by-Design As PAT and Quality -by-design (QbD) become an integral part of the regulatory framework, automation group ABB argues more
Medical Robotics LBR Med
Medical Robotics LBR Med EN KUKA, a proven robotics partner. Discerning users around the world value KUKA as a reliable partner. KUKA has branches in over 30 countries, and for over 40 years, we have been
Do not copy BME Abbreviated Course Title (19 spaces or less): Design of Biomedical Systems and Devices
without the express written consent of the instructor. Department of Biomedical Engineering Course Title: Design of Biomedical Systems & Devices Instructors: Michael Christie/ Hamid Shahrestani Required
Taking a broader view
Taking a broader view A brief introduction to DNV GL 1 SAFER, SMARTER, GREENER We are a global classification, certification, technical assurance and advisory company 2 In a challenging world we make businesses
Progressive Licensing and the Modernization of the Canadian Regulatory Framework
Progressive Licensing and the Modernization of the Canadian Regulatory Framework Workshop on Implementation of ICH Quality Guidelines Beijing, China 3-5 December, 2008 Mike Ward Health Canada 1 DISCLAIMER
CDRH PMA Critical to Quality (CtQ) Pilot
1 Informative series of workshops featuring emerging trends in medical technology regulatory science, MDIC projects and subject matter experts sharing perspectives, progress and opportunities. CDRH PMA
The Medical Device Regulation: Transitioning between old and new
Association of British Healthcare Industries The Medical Device Regulation: Transitioning between old and new www.abhi.org.uk www.bdia.org.uk Introduction In May 2017, the new Medical Device Regulation
GE Healthcare. Vivid S5. Cardiovascular ultrasound system
GE Healthcare Vivid S5 Cardiovascular ultrasound system Versatility. It s a new design concept one that leverages our miniaturization expertise gained from the Vivid i and our performance expertise of
AMERICAN MADE. experience INNOVATION. We are American Made
AMERICAN MADE INNOVATION We are American Made experience INNOVATION Quality and Innovation with American-Made Values American innovation and ingenuity are known around the world. At Phillips Precision
Innovation Progress and Future Outlook
Innovation Progress and Future Outlook David Whitlock, Director of Division Programs and Innovations Office January 29, 2016 Safety Moment January 29, 2016 2 Think 5 Ahead Program Encourages our people
SURGERY STRATEGIC CLINICAL NETWORK EVIDENCE DECISION SUPPORT PROGRAM. New ideas & Improvements
SURGERY STRATEGIC CLINICAL NETWORK EVIDENCE DECISION SUPPORT PROGRAM 2014 Revision (v3) New ideas & Improvements Department of Surgery Evidence Decision Support Program Resource Tool Box Regional Clinical
2008 Course Programs Schedule
2008 Course Programs Schedule Basic Laboratory Safety Laboratory Safety Biostatistics for the Non-Statistician - Basic Applied cgmps for Pharmaceutical and Allied Industries Good Clinical Practices (GCP)
Global Harmonization Task Force
Global Harmonization Task Force How to minimize risks without constraining innovation and harming free trade The role of international standards And their application at regional and national levels Cornelis
CDER s Office of Pharmaceutical Quality (OPQ): Delivering on the 21 st Century Quality Goals
CDER s Office of Pharmaceutical Quality (OPQ): Delivering on the 21 st Century Quality Goals Lawrence X. Yu, Ph.D. Director (acting) Office of Pharmaceutical Science Food and Drug Administration IFPAC
Piloting MDevSPICE - the Medical Device Software Process Assessment Framework
Piloting MDevSPICE - the Medical Device Software Process Assessment Framework Marion Lepmets Regulated Software Research Centre Dundalk Institute of Technology Dundalk, Ireland marion.lepmets@dkit.ie Fergal
Deciding When to Submit a 510(k) for a Software Change to an Existing Device Draft Guidance for Industry and Food and Drug Administration Staff
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 Deciding When to Submit a 510(k) for a Software Change to an Existing Device Draft Guidance for Industry and Food
TABLE OF CONTENTS DUPONT TYVEK MEDICAL PACKAGING TRANSITION PROJECT (MPTP) EXECUTIVE SUMMARY JUNE 2016 THE FINAL PHASE EXECUTIVE SUMMARY 2
DUPONT TYVEK MEDICAL PACKAGING TRANSITION PROJECT (MPTP) EXECUTIVE SUMMARY THE FINAL PHASE TABLE OF CONTENTS EXECUTIVE SUMMARY 2 COMMERCIALIZATION 3 4 REGULATORY 5 6 TECHNICAL 7 8 For more information,
Industry at a Crossroads: The Rise of Digital in the Outcome-Driven R&D Organization
Accenture Life Sciences Rethink Reshape Restructure for better patient outcomes Industry at a Crossroads: The Rise of Digital in the Outcome-Driven R&D Organization Accenture Research Note: Key findings
Parallel Prototyping and the Engineer s Dilemma
ISO 9001:2008 Certified Parallel Prototyping and the Engineer s Dilemma Develop innovative products quickly, with superior quality, while controlling cost Heatron, Inc. 3000 Wilson Avenue, Leavenworth,
Technical Documentation - Key pit falls
Technical Documentation - Key pit falls Itoro Udofia, PhD Global Head, Orthopaedic & Dental Devices Presented by Ibim Tariah Ph.D Technical Director Healthcare Solutions September 2012 TFD00101ENUK Overview
AUTO INJECTORS & PEN INJECTORS: A USER-CENTRIC DESIGN APPROACH
AUTO INJECTORS & PEN INJECTORS: A USER-CENTRIC DESIGN APPROACH In this article, SHL Group provides insights into their injection device design processes and culture, emphasising their focus on the patient
Medical Devices for the IoT Design Challenges Tilo Borchardt
Medizin- und Informationstechnik AG 2016-06-14 Chemnitzer Seminar Kardiologische Funktionsdiagnostik Medical Devices for the IoT Design Challenges Tilo Borchardt Vitalfunktions-Monitoring Telemonitoring
ICH Q10 Pharmaceutical Quality System
Safeguarding public health ICH Q10 Pharmaceutical Quality System An EU Regulator s Perspective Presentation overview Why does Q10 exist and what were the desired outcomes Content of the Q10 step 2 document
of Temperatures and other Physical Parameters
BIOMERIEUX PERFORMANCE SOLUTIONS Quality & Compliance Services Monitoring & Traceability of Temperatures and other Physical Parameters How do you ensure your environmental monitoring quality? In case of
JUST SCRATCHING THE SERVICE
CONTRACT MANUFACTURING, PACKAGING & NEW EQUIPMENT TECHNOLOGY FOR THE BIOPHARM/PHARMACEUTICAL INDUSTRY OFFICIAL MEDIA SPONSOR OF W W W. P H A R M P R O. C O M V O L U M E 3 0, N U M B E R 4 M AY 2 0 1 5
Mike Hess Vice President, Innovation Medtronic Inc
Mike Hess Vice President, Innovation Medtronic Inc Medtronic Today World headquarters Minneapolis European headquarters Lausanne Asia/Pacific headquarters Singapore $40-60 Billion market capitalization
USP Research & Innovation Program
USP Research & Innovation Program Ding Ming, Ph.D. Vice president, Research & Innovation United States Pharmacopeial Convention (USP) October 13, 2016 USP Programs and Products Impact Millions Worldwide
YOUR INJECTION MOLDING PARTNER
YOUR INJECTION MOLDING PARTNER crescentind.com 70 East High Street New Freedom, PA 17349 717.746.0663 WHO WE ARE Engineering-Driven, Technology-Based Injection Molder At Crescent Industries, our expertise
J.P. Morgan Healthcare Conference Summary Transcript
J.P. Morgan Healthcare Conference Summary Transcript Good afternoon, everyone. I'm Shigeo Taniuchi. I'm President and COO of Santen Pharmaceutical. I joined Santen in 1996, and I became the President and
2. Evidence themes and their importance along the development path
1. The issue On 12 th July 2017, MedCity, Digital Health.London and BSI hosted a Digital Health Technology and Evidence Stakeholder workshop. It brought together the key experts for the innovation development
Moving from R&D to Manufacture
Moving from R&D to Manufacture NSF I/UCRC Annual Meeting January 9, 2014 Clara Asmail Senior Technical Advisor NIST MEP Agenda Overview of NIST MEP program Technology Acceleration and MEP s role Sampling
In the heart of Industrial electronics
In the heart of Industrial electronics DRIVES SAFETY, SECURITY BUILDING CONTROL MEDICAL ELEVATORS INSTRUMENTATION, MEASUREMENT INDUSTIAL AUTOMATION POWER & UTILITIES ESCALATORS RAILWAY, MARINE & OTHER
Digital Medical Device Innovation: A Prescription for Business and IT Success
10 September 2018 Digital Medical Device Innovation: A Prescription for Business and IT Success A Digital Transformation is reshaping healthcare. New technology, mobility, and advancements in computing
Medicines Manufacturing in the UK 2017
Medicines Manufacturing in the UK 2017 Moderator: Magda Papadaki, PhD Head of Manufacturing Innovation The Association of the British Pharmaceutical Industry Medicines Manufacturing Industry Partnership
Quality by Design, Clinical Relevance & Lifecycle Considerations
Quality by Design, Clinical Relevance & Lifecycle Considerations Robert Iser Acting Director Office of Process & Facilities / OPQ / CDER IFPAC 2016 1 FDA Quality Related Guidance and Initiatives Initiatives
Epilogue. Simona Rocchi Erasmus University, Centre for Environmental Studies, Rotterdam
Simona Rocchi Erasmus University, Centre for Environmental Studies, Rotterdam Epilogue Enhancing Sustainable Innovation by Design An Approach to the Co-creation of Economic, Social and Environmental Value
February 5, 2010 VIA ELECTRONIC SUBMISSION
February 5, 2010 VIA ELECTRONIC SUBMISSION Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, rm. 1061 Rockville, MD 20852 Re: Current Good Manufacturing Practice
Driving Innovation. Connect and Catalyse. Medicines and Healthcare the Global perspective (+10 years) Zahid Latif
Connect and Catalyse Medicines and Healthcare the Global perspective (+10 years) Zahid Latif % GDP spent on health OECD countries spent nearly $3.5trn in 2005 ($4.6 trillion in 2008) on healthcare services
The Transition to Model-Based Drug Development. Phase 1: Formalizing the Pharmacometric Process
1780 Wehrle Drive Suite 110 Buffalo, New York 14221 716.633.3463 cognigencorp.com The Transition to Model-Based Drug Development Phase 1: Formalizing the Pharmacometric Process By Thaddeus H. Grasela,
STRATEGIC FRAMEWORK Updated August 2017
STRATEGIC FRAMEWORK Updated August 2017 STRATEGIC FRAMEWORK The UC Davis Library is the academic hub of the University of California, Davis, and is ranked among the top academic research libraries in North
WANT TO PARTICIPATE IN RESEARCH? THERE S AN APP FOR THAT!
WANT TO PARTICIPATE IN RESEARCH? THERE S AN APP FOR THAT! SECURITY AND PRIVACY ISSUES WITH THE INCREASED USE OF CONNECTED DEVICES, APPS, AND SOCIAL MEDIA IN RESEARCH. PRESENTED BY: DAVID MATA, SENIOR ASSOCIATE,
WHO WE ARE MISSION STATEMENT
WHO WE ARE Parker Life Sciences offers reliable fluidic and motion control products, MetaModules, and systems to customers in life sciences and in analytical instrumentation markets. As part of Parker
Guidance for Industry and FDA Staff Use of Symbols on Labels and in Labeling of In Vitro Diagnostic Devices Intended for Professional Use
Guidance for Industry and FDA Staff Use of Symbols on Labels and in Labeling of In Vitro Diagnostic Devices Intended for Professional Use Document issued on: November 30, 2004 The draft of this document
HealthTech: What does it mean for compliance?
HealthTech: What does it mean for compliance? May 2018 Agenda 11:15 AM 11:30 AM Introduction Kathleen Meriwether, Americas Leader - Life Sciences Fraud Investigation & Dispute Services, EY 11:30 AM 12:15
Clinical Forum Attendee Sample Job Titles
Account Executive Account Manager Account Manager, New Sales Development - Europe Advisor, Global Medical Channels and ecapabilities Area Sales Director Assistant Director.Assistant Director Pharm. Tr.
'INNOVATIVE SOLUTIONS FOR RESEARCH IN HEALTHCARE' Developing a novel approach to deliver better precision medicine in Europe The EMA standpoint
'INNOVATIVE SOLUTIONS FOR RESEARCH IN HEALTHCARE' Developing a novel approach to deliver better precision medicine in Europe The EMA standpoint STOA workshop - European Parliament, 10 January 2019 Presented
Conformity assessment procedures for hip, knee and shoulder total joint replacements
1. INTRODUCTION NBRG 307/07 It is the primary purpose of this document to provide guidance to Manufacturers and Notified Bodies in dealing with the application of Directive 2005/50/EC on the reclassification
MEDICAL FROM TO FINISH. Product Design Capabilities
MEDICAL FROM THOUGHT TO FINISH Product Design Capabilities About Sparton Corporation Sparton has become the partner of choice for companies that want to design and manufacture the most complex electronic
Progress in FDA s Drug Product Quality Initiative. Janet Woodcock, M.D. November 13, 2003
Progress in FDA s Drug Product Quality Initiative Janet Woodcock, M.D. November 13, 2003 Impetus for Initiative: Modernization and continuous improvement in pharmaceutical manufacturing sector slow compared
Guidance for Industry
Guidance for Industry Formal Dispute Resolution: Scientific and Technical Issues Related to Pharmaceutical CGMP U.S. Department of Health and Human Services Food and Drug Administration Center for Drug
Fresenius Medical Care North America (FMCNA)
4 th Annual Lab Quality Confab and Process Improvement Institute November 2 3, 2010 Spectra Labs Turns to ISO 15189 s QMS to Advance Performance and Gain International Recognition Presented by: Chinu M.
Vivid S5. Cardiovascular ultrasound system. GE Healthcare. Davis Medical
GE Healthcare Vivid S5 Cardiovascular ultrasound system Versatility. It s a new design concept one that leverages our miniaturization expertise gained from the Vivid i and our performance expertise of
Microwave and Microelectronics
Microwave and Microelectronics MISSION SYSTEMS 2 BAE Systems Mission Systems Microwave and Microelectronics 3 Manufacturing Success Microwave and Microelectronics Mission Systems provides manufacturing
TECHNOLOGY. In hospitals the authority to make decisions DECISION MAKING
TECHNOLOGY DECISION MAKING In hospitals the authority to make decisions about the purchase and use of technology is usually diffused among a great many people. Sometimes chief executive officers will approve
NEWS RELEASE. Life sciences companies tout their expertise in India
For Immediate Release 2014MIT0016-000196 Feb. 19, 2014 NEWS RELEASE International Trade and Responsible for the Asia Pacific Strategy and Multiculturalism Life sciences companies tout their expertise in
Draft Plan of Action Chair's Text Status 3 May 2008
Draft Plan of Action Chair's Text Status 3 May 2008 Explanation by the Chair of the Drafting Group on the Plan of Action of the 'Stakeholder' Column in the attached table Discussed Text - White background
The FDA: Merging Innovation and Opportunity to Impact Public Health
The FDA: Merging Innovation and Opportunity to Impact Public Health Jonathan Sackner-Bernstein, MD, FACC Associate Center Director, Post Market Operations Center for Devices and Radiologic Health U.S.
HARNESSING TECHNOLOGY
HARNESSING TECHNOLOGY TO TRANSFORM PUBLIC SERVICE DELIVERY AND OUTCOMES ACCENTURE PUBLIC SERVICE TECHNOLOGY CONSULTING Remember when public service organizations viewed IT as a cost center separate from
Global Perspectives on Clinical Engineering Trends Yadin David, Ed.D., P.E., C.C.E., FAACE, FAIMBE
Second WHO Global Forum on Medical Devices Priority Medical Devices for Universal Health Coverage 22-24 November 2013, Geneva, Switzerland Global Perspectives on Clinical Engineering Trends Yadin David,